One-two punch drug combination offers hope for pancreatic cancer therapy

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a combination of two anti-cancer compounds that shrank pancreatic tumors in mice—supporting the immediate evaluation of the drugs in a clinical trial. U.S. Food and Drug Administration (FDA)–approved versions of the compounds are used today to treat certain leukemias and solid tumors, including melanoma. The study was published in Nature Cell Biology.

Read more

6 SKIN CARE TIPS THAT DERMATOLOGISTS USE THEMSELVES

Board-certified dermatologists are experts when it comes to the skin, hair and nails, diagnosing and treating more than 3,000 diseases and conditions, including skin cancer, acne, psoriasis and eczema. They also help patients address their cosmetic concerns, such as tattoo removal, scarring, and aging skin. But do you ever wonder what skin care tips dermatologists use themselves to maintain healthy skin? In recognition of National Healthy Skin Month in November, dermatologists from the American Academy of Dermatology are sharing six skin care tips they recommend to all of their patients—and actually use themselves.

Read more

NEARLY $40,000 RAISED FOR SKIN CANCER PREVENTION AND DETECTION THROUGH “SKIN CANCER, TAKE A HIKE!™”

This fall, a group of skin cancer advocates and their families and friends in both Chicago and Phoenix hiked three miles to say “Skin Cancer, Take a Hike!” Together, they raised nearly $40,000 for SPOT Skin Cancer™ benefiting the American Academy of Dermatology’s skin cancer prevention and detection programs, including free skin cancer screenings, sunscreen dispensers, and permanent shade structures in outdoor spaces where children learn and play.

Read more

Johns Hopkins researchers identify one driver of melanoma spread

Using a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in lab-grown melanoma cells, a team led by a Johns Hopkins Kimmel Cancer Center researcher identified highly unstable RNA molecules in human melanomas, including a novel miR-211 target gene DUSP3.

Read more

Huntsman Cancer Institute Introduces Cancer Screening and Education Bus to the Community

Today Huntsman Cancer Institute (HCI) at the University of Utah unveiled the Cancer Screening and Education bus. This new, state-of-the-art mobile outreach clinic brings HCI’s clinical and educational expertise and the latest screening technology to residents across Utah, including those who live in distant geographic areas and rural communities.

Read more